The Cancer Research UK Cambridge Institute (CRUK CI), housed in the Li Ka Shing Centre, focuses on tackling questions relating to cancer diagnosis, treatment and prevention, supported by world-class core scientific facilities.
Our aim is to be a focus for the practical application of high-quality basic research, forming a bridge between the world-class science of the University of Cambridge and its environment, and Addenbrooke's Hospital.
The Institute's location on the Cambridge Biomedical Campus, to the south of Cambridge, and its membership of many collaborative initiatives are vital in helping us to achieve our goals.
The Cambridge Biomedical Campus is home to Addenbrooke's Hospital, the University of Cambridge teaching hospital, and many of our collaborating institutes, including the MRC Laboratory for Molecular Biology, the Hutchison/MRC Research Centre, the Strangeways Research Laboratories for Genetic Epidemiology and the Cambridge Institute for Medical Research. In the wider Cambridge area we also have extensive links with the Wellcome Trust Sanger Institute, and the European Bioinformatics Institute.
The CI is also a member of the Organisation of European Cancer Institutes (OECI).
The CI is core funded by Cancer Research UK, which allows our researchers to focus on answering challenging research questions. In addition group leaders apply for grants from external funding agencies to support their work, and around 50% of our PhD students and postdocs are externally funded.
In addition, the CI contributes to many of the collaborative centres and initiatives that Cancer Research UK helps to support, including the Cambridge Biomedical Research Centre, the Experimental Cancer Medicine Centre, and the Cambridge Pancreatic Cancer Centre.
Cambridge Cancer Centre
The CI is a key member of the Cambridge Cancer Centre a partnership between the University of Cambridge, Cancer Research UK, Cambridge University Hospitals NHS Foundation Trust and Cambridge University Health Partners. The aim of the centre is to bring together researchers in biology, medicine, maths, physics, chemistry and biology, as well as clinicians and pharmaceutical companies from across the Cambridge region, whose research as implications for the prevention, detection or treatment of cancer. A key focus of the centre is translating the work done in Cambridge laboratories into benefits for patients in the clinic.
The Institute Director is Professor Simon Tavaré. Professor Tavaré is group leader of the statistics and computational biology laboratory, and is responsible for fostering multi-disciplinary relationships between the CI, University of Cambridge and Addenbrooke's Hospital, and directing the Institute's research strategy.
The CI's Director of Operations is Dr John Wells. Dr Wells is responsible for the operational management of the Institute, including the operating plan and budget and CI committees. In addition Dr Wells is the main link between the CI and other Cancer Research UK central departments.
Our former deputy director, Fiona Watt, is now Director of the Centre for Stem Cells and Regenerative Medicine at King's College London.